• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非复制型单纯疱疹病毒1型细菌人工染色体(HSV-1 BAC)基因组载体中删除多个非必需元件的协同效应在其生存能力中起着关键作用。

Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability.

作者信息

Ventosa M, Ortiz-Temprano A, Khalique H, Lim F

机构信息

Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.

出版信息

Gene Ther. 2017 Jul;24(7):433-440. doi: 10.1038/gt.2017.43. Epub 2017 May 29.

DOI:10.1038/gt.2017.43
PMID:28553928
Abstract

Nonreplicative Herpes simplex virus type-1 (HSV-1) genomic vectors have already entered into clinical trials for neurological gene therapy thanks to their scalable growth in permissive cells. However, the small transgene capacity of this type of HSV-1 vectors currently used in the clinic represents an important limiting factor as a gene delivery system. To develop high-capacity nonreplicative genomic HSV-1 vectors, in this study we have characterized a series of multiply deleted mutants which we have constructed in bacterial artificial chromosomes (BACs), removing up to 24 kb of unstable or dispensable genomic sequences to allow insertion of transgenes up to this size. We show that synergistic effects of deletions of: the HSV-1 replication origins ori and ori, the HSV-1 internal repeat region, the remaining ICP4 gene copy and the genes encoding for ICP27, U56, U55, can severely reduce the growth of these HSV-1 vectors. Given that several of these elements have been characterized as 'non-essential' for viral growth in cell culture by single-deletion experiments of wild-type HSV-1, our study highlights the need to re-evaluate their functional contribution in the context of multiply deleted nonreplicative HSV-1 genomic vectors. Our BAC mutants described here can serve as useful starting platforms to accelerate HSV-1 vector development.

摘要

非复制型单纯疱疹病毒1型(HSV-1)基因组载体因其在允许细胞中的可扩展性生长,已进入神经基因治疗的临床试验阶段。然而,目前临床上使用的这种类型的HSV-1载体的转基因容量较小,这是其作为基因递送系统的一个重要限制因素。为了开发高容量的非复制型基因组HSV-1载体,在本研究中,我们对一系列在细菌人工染色体(BAC)中构建的多重缺失突变体进行了表征,去除了多达24 kb的不稳定或可有可无的基因组序列,以允许插入该大小的转基因。我们表明,HSV-1复制起点ori和ori、HSV-1内部重复区域、剩余的ICP4基因拷贝以及编码ICP27、U56、U55的基因缺失的协同效应,可严重降低这些HSV-1载体的生长。鉴于通过野生型HSV-1的单缺失实验,这些元件中的几个已被表征为细胞培养中病毒生长的“非必需”元件,我们的研究强调了在多重缺失的非复制型HSV-1基因组载体背景下重新评估其功能贡献的必要性。我们在此描述的BAC突变体可作为加速HSV-1载体开发的有用起始平台。

相似文献

1
Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability.在非复制型单纯疱疹病毒1型细菌人工染色体(HSV-1 BAC)基因组载体中删除多个非必需元件的协同效应在其生存能力中起着关键作用。
Gene Ther. 2017 Jul;24(7):433-440. doi: 10.1038/gt.2017.43. Epub 2017 May 29.
2
Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.利用细菌人工染色体中缺失ICP27的超大HSV-1 DNA构建用于单纯疱疹病毒扩增子载体的改良无辅助病毒包装系统。
Mol Ther. 2001 Apr;3(4):591-601. doi: 10.1006/mthe.2001.0294.
3
Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.用于生产复制缺陷型单纯疱疹病毒1型(HSV-1)基因治疗载体的工程细胞系。
Biotechnol Bioeng. 2009 Mar 1;102(4):1087-97. doi: 10.1002/bit.22123.
4
Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.多种立即早期基因缺陷型单纯疱疹病毒载体可实现高效的基因传递至培养中的神经元,并在体内广泛地将基因传递至中枢神经系统。
J Virol. 2001 May;75(9):4343-56. doi: 10.1128/JVI.75.9.4343-4356.2001.
5
Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.从1型单纯疱疹病毒基因组中删除S成分反向重复序列c'以及非必需基因U(S)1至U(S)5,会严重损害细胞培养中的病毒有效感染以及大鼠中枢神经系统中的发病机制。
J Neurovirol. 1997 Aug;3(4):247-64. doi: 10.3109/13550289709029466.
6
A haploid HSV-1 genome platform for vector development: testing of the tetracycline-responsive switch shows interference by infected cell protein 0.用于载体开发的单倍体单纯疱疹病毒1型基因组平台:四环素反应开关的测试显示受感染细胞蛋白0存在干扰。
J Gene Med. 2016 Oct;18(10):302-311. doi: 10.1002/jgm.2929.
7
Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.单纯疱疹病毒/腺相关病毒(HSV/AAV)杂交扩增载体的构建与包装。
Cold Spring Harb Protoc. 2012 Mar 1;2012(3):352-6. doi: 10.1101/pdb.prot068114.
8
Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes.等位基因置换:一种允许对1型单纯疱疹病毒基因组进行快速操作的应用。
Gene Ther. 1999 May;6(5):922-30. doi: 10.1038/sj.gt.3300887.
9
HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.单纯疱疹病毒/腺相关病毒杂交扩增载体可延长人胶质瘤细胞中的转基因表达。
Hum Gene Ther. 1997 Feb 10;8(3):359-70. doi: 10.1089/hum.1997.8.3-359.
10
Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.通过细菌人工染色体介导系统构建的携带白细胞介素18和可溶性B7-1双武装的三基因缺失溶瘤单纯疱疹病毒载体。
Cancer Res. 2005 Dec 1;65(23):10663-8. doi: 10.1158/0008-5472.CAN-05-2534.

引用本文的文献

1
Genomic Size Is Critical to Guarantee the Genomic Stability of Non-Replicative HSV1 Vectors.基因组大小对于保证非复制型单纯疱疹病毒1型(HSV1)载体的基因组稳定性至关重要。
Int J Mol Sci. 2025 May 21;26(10):4941. doi: 10.3390/ijms26104941.
2
Effects of US7 and UL56 on Cell-to-Cell Spread of Human Herpes Simplex Virus 1.US7 和 UL56 对人单纯疱疹病毒 1 细胞间传播的影响。
Viruses. 2023 Nov 14;15(11):2256. doi: 10.3390/v15112256.

本文引用的文献

1
A haploid HSV-1 genome platform for vector development: testing of the tetracycline-responsive switch shows interference by infected cell protein 0.用于载体开发的单倍体单纯疱疹病毒1型基因组平台:四环素反应开关的测试显示受感染细胞蛋白0存在干扰。
J Gene Med. 2016 Oct;18(10):302-311. doi: 10.1002/jgm.2929.
2
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.用于高效转导非神经元细胞且无细胞毒性的单纯疱疹病毒载体设计。
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1632-41. doi: 10.1073/pnas.1423556112. Epub 2015 Mar 16.
3
Gene therapy clinical trials worldwide to 2012 - an update.
全球 2012 年之前的基因治疗临床试验-更新。
J Gene Med. 2013 Feb;15(2):65-77. doi: 10.1002/jgm.2698.
4
Gene therapy for pain: results of a phase I clinical trial.疼痛的基因治疗:I 期临床试验结果。
Ann Neurol. 2011 Aug;70(2):207-12. doi: 10.1002/ana.22446. Epub 2011 Jul 27.
5
A new positive/negative selection scheme for precise BAC recombineering.一种用于精确BAC重组工程的新的正负选择方案。
Mol Biotechnol. 2009 May;42(1):110-6. doi: 10.1007/s12033-009-9142-3. Epub 2009 Jan 22.
6
Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-Related alterations in gene expression profiles.单纯疱疹病毒介导的胚胎体中Pax3和MyoD的表达导致基因表达谱中与谱系相关的改变。
Stem Cells. 2008 Dec;26(12):3119-29. doi: 10.1634/stemcells.2008-0417. Epub 2008 Sep 11.
7
A plaque neutralization method for arboviruses.一种用于虫媒病毒的蚀斑中和方法。
Proc Soc Exp Biol Med. 1967 Jul;125(3):741-7. doi: 10.3181/00379727-125-32194.
8
Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins.用于生产重组治疗性蛋白质的中国仓鼠卵巢细胞培养物支原体检测的聚合酶链反应(PCR)方法的开发。
Biologicals. 2004 Dec;32(4):183-93. doi: 10.1016/j.biologicals.2004.08.005.
9
Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli.溶源性研究。I. 溶源性大肠杆菌释放噬菌体的方式。
J Bacteriol. 1951 Sep;62(3):293-300. doi: 10.1128/jb.62.3.293-300.1951.
10
Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo.构建包含1型单纯疱疹病毒全长感染性克隆的可切除细菌人工染色体:从该克隆重建的病毒在体外和体内均表现出野生型特性。
J Virol. 2003 Jan;77(2):1382-91. doi: 10.1128/jvi.77.2.1382-1391.2003.